Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:37 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 523696 | NSE: FORTISMLR

Fortis Malar Hospitals Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹1.57Overvalued by 96.56%vs CMP ₹45.60

P/E (18.8) × ROE (0.6%) × BV (₹18.30) × DY (2.00%)

₹23.33Overvalued by 48.84%vs CMP ₹45.60
MoS: -95.5% (Negative)Confidence: 53/100 (Moderate)Models: 1 Under, 5 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹2.3731%Over (-94.8%)
Graham NumberEarnings₹31.5719%Over (-30.8%)
Earnings PowerEarnings₹23.2915%Over (-48.9%)
DCFCash Flow₹59.4815%Under (+30.4%)
Net Asset ValueAssets₹18.3610%Over (-59.7%)
Earnings YieldEarnings₹24.2010%Over (-46.9%)
Consensus (6 models)₹23.33100%Overvalued
Key Drivers: EPS CAGR 50.9% lifts DCF — verify sustainability. | ROE 0.6% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 50.9%

*Investments are subject to market risks

Investment Snapshot

40
Fortis Malar Hospitals Ltd scores 40/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health50/100 · Moderate
ROCE 0.8% WeakROE 0.6% WeakD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent
Smart Money50/100 · Moderate
Promoter holding at 62.7% Stable
Earnings Quality40/100 · Moderate
OPM contracting (5% → -1%) Declining
Quarterly Momentum25/100 · Weak
Revenue (4Q): -99% YoY DecliningProfit (4Q): -92% YoY Declining
Industry Rank35/100 · Weak
P/E 18.8 vs industry 75.2 Cheaper than peersROCE 0.8% vs industry 14.7% Below peersROE 0.6% vs industry 13.9% Below peers3Y sales CAGR: -100% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:37 am

Market Cap 85.4 Cr.
Current Price 45.6
Intrinsic Value₹23.33
High / Low 98.7/40.8
Stock P/E18.8
Book Value 18.3
Dividend Yield0.00 %
ROCE0.83 %
ROE0.56 %
Face Value 10.0
PEG Ratio0.37

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Fortis Malar Hospitals Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Fortis Malar Hospitals Ltd 85.4 Cr. 45.6 98.7/40.818.8 18.30.00 %0.83 %0.56 % 10.0
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Deccan Health Care Ltd 18.6 Cr. 7.50 24.4/6.658.44 44.00.00 %1.69 %1.18 % 10.0
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Dr Lal Pathlabs Ltd 22,178 Cr. 1,324 1,771/1,17640.4 1430.91 %28.9 %24.3 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Fortis Malar Hospitals Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 21.9020.6617.7618.1517.585.520.000.000.000.000.020.030.00
Expenses 20.3019.9318.2718.2318.675.040.880.470.410.370.350.410.33
Operating Profit 1.600.73-0.51-0.08-1.090.48-0.88-0.47-0.41-0.37-0.33-0.38-0.33
OPM % 7.31%3.53%-2.87%-0.44%-6.20%8.70%-1,650.00%-1,266.67%
Other Income 1.521.971.612.311.2659.690.830.560.560.774.610.520.52
Interest 1.491.421.351.301.260.390.010.000.000.000.000.000.00
Depreciation 2.783.442.672.722.911.060.000.000.000.000.000.000.00
Profit before tax -1.15-2.16-2.92-1.79-4.0058.72-0.060.090.150.404.280.140.19
Tax % 0.00%223.15%0.00%0.00%0.25%7.95%0.00%0.00%93.33%10.00%3.04%92.86%89.47%
Net Profit -1.15-6.99-2.93-1.79-4.0054.05-0.060.090.010.364.150.010.02
EPS in Rs -0.61-3.73-1.56-0.96-2.1328.84-0.030.050.010.192.210.010.01

Last Updated: March 3, 2026, 9:50 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:20 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 108.38117.93129.61140.56149.19144.59111.8769.2486.1885.9559.010.000.05
Expenses 99.39110.37123.31139.64147.44146.94114.5775.5882.7481.3860.222.141.46
Operating Profit 8.997.566.300.921.75-2.35-2.70-6.343.444.57-1.21-2.14-1.41
OPM % 8.29%6.41%4.86%0.65%1.17%-1.63%-2.41%-9.16%3.99%5.32%-2.05%-2,820.00%
Other Income 6.857.637.217.958.4410.0311.1115.107.396.6464.882.726.42
Interest 0.460.510.400.460.380.517.817.206.566.074.300.010.00
Depreciation 1.992.713.163.944.214.3812.5312.8812.5312.159.360.000.00
Profit before tax 13.3911.979.954.475.602.79-11.93-11.32-8.26-7.0150.010.575.01
Tax % 34.43%34.25%35.58%30.20%40.54%26.16%-25.48%-30.48%0.12%120.97%9.36%31.58%
Net Profit 8.787.866.423.113.322.06-8.89-7.87-8.27-15.4845.320.394.54
EPS in Rs 4.724.233.451.671.781.10-4.74-4.20-4.41-8.2624.180.212.42
Dividend Payout % 10.60%11.84%14.50%0.00%0.00%0.00%0.00%0.00%0.00%0.00%175.93%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-10.48%-18.32%-51.56%6.75%-37.95%-531.55%11.47%-5.08%-87.18%392.76%-99.14%
Change in YoY Net Profit Growth (%)0.00%-7.84%-33.24%58.31%-44.70%-493.60%543.03%-16.56%-82.10%479.95%-491.90%

Fortis Malar Hospitals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-100%
Compounded Profit Growth
10 Years:-26%
5 Years:15%
3 Years:27%
TTM:190%
Stock Price CAGR
10 Years:5%
5 Years:7%
3 Years:3%
1 Year:11%
Return on Equity
10 Years:-4%
5 Years:-11%
3 Years:-10%
Last Year:1%

Last Updated: September 5, 2025, 3:30 pm

Balance Sheet

Last Updated: February 1, 2026, 4:49 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 18.6118.6118.6218.6818.7018.7618.7618.7618.7618.7618.7618.7618.76
Reserves 66.2072.6379.0280.8784.3586.6277.6569.9961.3745.4290.7111.4515.62
Borrowings 0.000.000.000.000.000.0064.3457.1753.4146.400.000.000.00
Other Liabilities 16.6719.6832.5531.1446.0345.4632.8023.1827.3727.426.416.622.81
Total Liabilities 101.48110.92130.19130.69149.08150.84193.55169.10160.91138.00115.8836.8337.19
Fixed Assets 17.6317.7124.5024.5923.7921.8581.0868.5257.6247.410.000.000.00
CWIP 0.640.640.360.610.720.730.090.360.060.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 83.2192.57105.33105.49124.57128.26112.38100.22103.2390.59115.8836.8337.19
Total Assets 101.48110.92130.19130.69149.08150.84193.55169.10160.91138.00115.8836.8337.19

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 4.814.3910.47-8.588.79-15.97-0.30-0.866.845.61-7.301.54
Cash from Investing Activity + -0.555.34-21.8813.47-1.566.3449.88-27.518.230.50119.70-29.10
Cash from Financing Activity + -1.100.00-1.09-0.970.050.15-11.57-7.25-10.10-12.65-10.85-79.65
Net Cash Flow 3.169.73-12.513.927.28-9.4838.01-35.624.98-6.54101.55-107.21
Free Cash Flow 2.141.11-0.10-12.145.11-18.68-3.20-1.395.563.73-9.601.54
CFO/OP 103%133%235%-175%801%458%-143%204%220%121%188%81%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow8.997.566.300.921.75-2.35-67.04-63.51-49.97-41.83-1.21-2.14

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 13.1313.0316.9314.4914.6824.3912.1711.029.3213.500.00
Inventory Days 4.0213.2435.3928.3722.3018.0422.4442.3239.8931.710.00
Days Payable 153.41169.39286.36173.78277.45257.22323.72373.05428.91584.69
Cash Conversion Cycle -136.26-143.11-234.05-130.92-240.47-214.79-289.11-319.72-379.70-539.470.00
Working Capital Days 187.38163.79126.13152.64131.84155.53-55.01114.5521.60183.80-8.35
ROCE %17.17%14.19%11.83%5.02%5.90%3.24%-3.04%-7.15%-1.25%-0.77%-3.29%0.83%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 62.71%62.71%62.71%62.71%62.71%14.40%62.71%62.71%62.71%62.71%62.71%62.71%
DIIs 0.07%0.07%0.07%0.07%0.07%0.17%0.07%0.07%0.07%0.07%0.07%0.07%
Public 37.23%37.23%37.23%37.23%37.23%85.43%37.22%37.22%37.23%37.24%37.21%37.21%
No. of Shareholders 8,7318,6518,6309,79010,21316,45218,86021,54726,91827,83227,64427,022

Shareholding Pattern Chart

No. of Shareholders

Fortis Malar Hospitals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 0.2124.18-8.26-4.41-4.20
Diluted EPS (Rs.) 0.2124.18-8.26-4.41-4.20
Cash EPS (Rs.) 0.2029.15-1.782.272.67
Book Value[Excl.RevalReserv]/Share (Rs.) 16.1158.3634.2142.7247.31
Book Value[Incl.RevalReserv]/Share (Rs.) 16.1158.3634.2142.7247.31
Revenue From Operations / Share (Rs.) 0.0031.4645.8245.9436.92
PBDIT / Share (Rs.) 0.303.065.985.771.02
PBIT / Share (Rs.) 0.30-1.93-0.49-0.90-5.84
PBT / Share (Rs.) 0.3026.66-3.74-4.40-6.03
Net Profit / Share (Rs.) 0.2024.16-8.25-4.41-4.20
NP After MI And SOA / Share (Rs.) 0.2024.16-8.25-4.41-4.20
PBDIT Margin (%) 0.009.7413.0412.562.76
PBIT Margin (%) 0.00-6.12-1.09-1.97-15.82
PBT Margin (%) 0.0084.74-8.15-9.58-16.33
Net Profit Margin (%) 0.0076.81-18.01-9.60-11.36
NP After MI And SOA Margin (%) 0.0076.81-18.01-9.60-11.36
Return on Networth / Equity (%) 1.2941.40-24.12-10.32-8.86
Return on Capital Employeed (%) 1.91-3.29-0.88-1.31-7.59
Return On Assets (%) 1.0639.11-11.21-5.14-4.65
Asset Turnover Ratio (%) 0.000.460.570.520.38
Current Ratio (X) 5.1517.682.661.562.43
Quick Ratio (X) 5.1517.682.631.502.36
Dividend Payout Ratio (NP) (%) 20319.480.000.000.000.00
Dividend Payout Ratio (CP) (%) 20319.480.000.000.000.00
Earning Retention Ratio (%) -20219.480.000.000.000.00
Cash Earning Retention Ratio (%) -20219.480.000.000.000.00
Interest Coverage Ratio (X) 56.701.341.851.650.26
Interest Coverage Ratio (Post Tax) (X) 39.43-1.93-1.55-0.26-1.04
Enterprise Value (Cr.) 119.90-20.8280.0095.5890.44
EV / Net Operating Revenue (X) 0.00-0.350.931.111.31
EV / EBITDA (X) 207.33-3.627.148.8347.25
MarketCap / Net Operating Revenue (X) 0.001.481.041.251.50
Retention Ratios (%) -20219.480.000.000.000.00
Price / BV (X) 4.560.791.391.351.17
Price / Net Operating Revenue (X) 0.001.481.041.251.50
EarningsYield 0.000.51-0.17-0.07-0.07

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Fortis Malar Hospitals Ltd. is a Public Limited Listed company incorporated on 13/04/1989 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L85110PB1989PLC045948 and registration number is 045948. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 18.76 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesFortis Hospital, Sector 62, Mohali Punjab 160062Contact not found
Management
NamePosition Held
Mr. Daljit SinghChairman (Non - Executive) & Non Independent Direc
Mr. Chandrasekar RamasamyWhole Time Director
Ms. Richa Singh DebguptaNon Exe.Non Ind.Director
Ms. Shailaja ChandraIndependent Director
Ms. Suvalaxmi ChakrabortyIndependent Director
Dr. Ritu GargNon Exe.Non Ind.Director

FAQ

What is the intrinsic value of Fortis Malar Hospitals Ltd and is it undervalued?

As of 14 April 2026, Fortis Malar Hospitals Ltd's intrinsic value is ₹23.33, which is 48.84% lower than the current market price of ₹45.60, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (0.56 %), book value (₹18.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Fortis Malar Hospitals Ltd?

Fortis Malar Hospitals Ltd is trading at ₹45.60 as of 14 April 2026, with a FY2026-2027 high of ₹98.7 and low of ₹40.8. The stock is currently near its 52-week low. Market cap stands at ₹85.4 Cr..

How does Fortis Malar Hospitals Ltd's P/E ratio compare to its industry?

Fortis Malar Hospitals Ltd has a P/E ratio of 18.8, which is below the industry average of 75.17. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Fortis Malar Hospitals Ltd financially healthy?

Key indicators for Fortis Malar Hospitals Ltd: ROCE of 0.83 % is on the lower side compared to the industry average of 14.71%; ROE of 0.56 % is below ideal levels (industry average: 13.91%). Dividend yield is 0.00 %.

Is Fortis Malar Hospitals Ltd profitable and how is the profit trend?

Fortis Malar Hospitals Ltd reported a net profit of ₹0 Cr in Mar 2025. Compared to ₹-8 Cr in Mar 2022, the net profit shows an improving trend.

Does Fortis Malar Hospitals Ltd pay dividends?

Fortis Malar Hospitals Ltd has a dividend yield of 0.00 % at the current price of ₹45.60. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Fortis Malar Hospitals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports